Leica Biosystems Unites Pharma, Pathologists, and Oncologists to Help Shape the Future of Digital Pathology and Enable More Precise Patient Therapies
recent articles
Visiopharm A/S is introducing a novel and patent protected method for determining the HER2 status in tissue sections. This method represents a significant technological breakthrough that effectively addresses several of the practical issues...
Unlock Your Future: Embrace The Potential Of Pathology December 16, 2010 at 12 PM EST Amanda Lowe, President of Digital Pathology Consultants The practice of pathology is evolving rapidly and pathologists must prepare for tomorrow. Over the...
Projections for the mobile health industry show that by 2015 there will be 500 million people using mobile health applications on their smartphones, according to a new report by a Berlin-based market research...
Pathology Visions 2010 talks are now available online: Web collaborations for slide sharing, second opinions and social networking in digital pathologyChrystal Adams; AperioView PPT slidesAutomated quantification of dendritic spine density in...
...
Healthcare IT News (11/10, Manos) reported, "Leaders at the National Institutes of Health and its nonprofit Foundation for the National Institutes of Health (FNIH) said they would stand behind the advancement of research for the use of...
